Psychedelics Filament Health ships psilocybin drug to Australia, first country legally prescribing psychedelics The shipment was received by the medical cannabis company Little Green Pharma and its psychedelics subsidiary Rowan DunneJanuary 17, 2024
Canada Filament and Jaguar’s joint venture Magdalena imports Peruvian coca leaves to Vancouver The leaves were obtained from the Empresa Nacional de la Coca (ENACO) -- Peru's only authorized distributor Rowan DunneSeptember 22, 2023
Psychedelics Filament Health gets FDA approval for psilocybin studies on cancer-related anxiety and depression The clinical trials will examine the effects of the company's botanical psilocybin drug candidate PEX010 Rowan DunneAugust 10, 2023
Psychedelics Filament Health to list on Nasdaq through new business arrangement The transaction is expected to close in Q4 this year Rowan DunneJuly 19, 2023
Psychedelics NeoLumina Bioscience to develop Filament Health patented psilocybin as eating disorders treatment Filament will be licensing NeoLumina with its PEX010 drug and associated IP for commercial and clinical development Rowan DunneJuly 3, 2023
Medical and Pharmaceutical PharmAla Biotech and Filament Health partner to release MDMA capsules The capsules are GMP certified and will be used in clinical trials and by authorized patients Natalia Buendia CalvilloApril 11, 2023
Medical and Pharmaceutical Filament Health and Jaguar Health form botanical pharmaceutical joint venture The new venture is named after a river with great cultural significance to Indigenous peoples Natalia Buendia CalvilloJanuary 10, 2023
Canada Filament administers psilocybin to 14 participants in Health Canada sanctioned clinical trial Clinical trial will be conducted as part of the ATMA Journey Centre's psychedelic-assisted therapist training program Rowan DunneSeptember 1, 2022
Canada TheraPsil launches Project Solace, Filament Health offers support 'Largest' psilocybin access and data campaign intended to forward mission of promoting fungi-assisted psychotherapy Rowan DunneJuly 28, 2022
Psychedelics Filament Health undertakes innovative clinical trial FDA-approved psilocin study in California said to be first of its kind for industry Rowan DunneJuly 11, 2022